Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain

AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain

including AZ’s own Iressa (gefitinib) and Roche’s Tarceva (erlotinib).

J&J’s bispecific lung cancer antibody nabs FDA breakthrough status

J&J’s bispecific lung cancer antibody nabs FDA breakthrough status This type of mutation occurs in tumours that aren’t sensitive to treatment with first- and second-generation small-molecule EGFR inhibitors like AstraZeneca’s Iressa (gefitinib), Roche’s Tarceva (erlotinib)

Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC

Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC That study evaluated Cyramza alongside Roche’s Tarceva (erlotinib), where it demonstrated media progression-free survival of 19.4 months, compared to 12.4 months in the placebo-plus-Tarceva arm. ... Tarceva “is associated with increased toxicity

Tagrisso tops rival drugs on survival in first-line lung cancer

Tagrisso tops rival drugs on survival in first-line lung cancer The improvement in OS came over other drugs in the EGFR inhibitor class, namely AZ’s own Iressa (gefitinib) and Roche’s Tarceva (erlotinib), and according to AZ’s head of

AstraZenca to appeal NICE rejection of Tagrisso

AstraZenca to appeal NICE rejection of Tagrisso NICE agreed that Tagrisso extends progression-free (PFS) and overall survival (OS) compared with first generation EGFR-targeting drugs Iressa and Tarceva, but said the size of the benefit is unclear.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics